Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
INDUSTRY
×
Hemangioma, Cavernous, Central Nervous System
×
Clear all
Filters
3
NCT05085561
2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2
Completed
62 enrolled